Updated September 2026

A mattress topper founder pitched me and a partner. He'd already proven real sales in Ireland, and he wanted help getting into the US market and raising two to three million dollars, all framed around the mattress business.

After the pitch, my partner and I looked at each other and neither of us thought the mattress topper was the real opportunity. It was his earlier stage second product, a neurostimulation wound care dressing using the same core material. So we structured a proposed retainer plus equity engagement around building toward that instead.

The mattress topper had already proven the underlying technology, a lab verified pathogen barrier with zero return rate, real international traction. But wound care has stronger clinical market margins and pull, and bridging him into the US with real scientific credibility makes both products stronger at once. That's what justified retainer plus equity over a flat fee.

The plan moved to pursuing scientific validation through my own network, connecting him to a sleep apnea device company for a possible bundled product ecosystem, and building out a formal retainer plus equity proposal.

Listen for the second product inside the first pitch. It's often worth more than what they actually asked you to help sell.

I looked past what he thought he was selling me and helped him see the bigger version of his own company.

About this story

When2026
Kind of storyInsider truth
Told byJesse Fowler, in his own voice
Full recordThe story in Jesse Fowler's own record
CreditCreated by Common Ground